Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Diehl V, Fuchs M; GHSG.
Diehl V, et al.
Transfus Apher Sci. 2007 Aug;37(1):37-41. doi: 10.1016/j.transci.2007.04.004. Epub 2007 Aug 21.
Transfus Apher Sci. 2007.
PMID: 17714996
Review.
MOPP and/or ABVD and furthermore the alternating MOPP/ABVD or the MOPP/ABV hybrid with and without the help of consolidative radiation resulted in around 70% long term survival rates, 30-40% of patients experienced tumor progression or relapses within 5 years. This led the German …
MOPP and/or ABVD and furthermore the alternating MOPP/ABVD or the MOPP/ABV hybrid with and without the help of consolidative radiation resul …